Compounds > zidovudine
Page last updated: 2024-08-23

zidovudine and Aplasia Pure Red Cell

zidovudine has been researched along with Aplasia Pure Red Cell in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's5 (62.50)18.2507
2000's1 (12.50)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujita, J; Haranaga, S; Higa, F; Nakamura, K; Tamayose, M; Tasato, D; Tateyama, M; Yara, S1
Kulasegaram, R; Rangarajan, S; van der Walt, J; Weinkove, R1
Dervenoulas, JG; Gogas, HJ; Lazanas, MC; Megalou, AA; Raptis, SA1
Duchatelle, V; Durand, F; Hermine, O; Karras, A; Rabian, C; Valla, D; Viard, JP; Zylberberg, H1
Bani-Sadr, F; Hoff, J; Raffi, F1
Dickinson, BP; Flanigan, T; Mega, A; Mileno, MD; Mylonakis, E; Rich, JD; Schiffman, FJ1
Barreto, L; Blanche, P; Gombert, B; Sicard, D; Silberman, B1
Cohen, H; Machin, SJ; Matthey, F; Miller, RF; Weller, IV; Williams, I1

Other Studies

8 other study(ies) available for zidovudine and Aplasia Pure Red Cell

ArticleYear
Pure red cell aplasia induced by lamivudine without the influence of zidovudine in a patient infected with human immunodeficiency virus.
    Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:15

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Biopsy, Needle; Bone Marrow; Diagnosis, Differential; HIV Infections; Humans; Lamivudine; Male; Platelet Count; Red-Cell Aplasia, Pure; Young Adult; Zidovudine

2014
Zidovudine-induced pure red cell aplasia presenting after 4 years of therapy.
    AIDS (London, England), 2005, Nov-18, Volume: 19, Issue:17

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Humans; Male; Red-Cell Aplasia, Pure; Time Factors; Zidovudine

2005
Zidovudine-responsive pure red cell aplasia as initial manifestation of HIV infection.
    AIDS (London, England), 1993, Volume: 7, Issue:2

    Topics: Adult; HIV Infections; Humans; Male; Red-Cell Aplasia, Pure; Zidovudine

1993
Severe anoxic hepatic necrosis in an HIV-1-hepatitis C virus-co-infected patient starting antiretroviral triple combination therapy.
    AIDS (London, England), 1998, May-07, Volume: 12, Issue:7

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Drug Therapy, Combination; Hepatitis C; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Necrosis; Red-Cell Aplasia, Pure; Reverse Transcriptase Inhibitors; Zidovudine

1998
[Erythroblastopenia secondary to zidovudine].
    La Revue de medecine interne, 1998, Volume: 19, Issue:7

    Topics: Anti-HIV Agents; Female; Humans; Middle Aged; Red-Cell Aplasia, Pure; Zidovudine

1998
Persistent parvovirus B19 related anemia of seven years' duration in an HIV-infected patient: complete remission associated with highly active antiretroviral therapy.
    American journal of hematology, 1999, Volume: 60, Issue:2

    Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Erythrocyte Transfusion; HIV Infections; Humans; Immunoglobulins, Intravenous; Lamivudine; Male; Parvoviridae Infections; Parvovirus B19, Human; Red-Cell Aplasia, Pure; Remission Induction; Ritonavir; Saquinavir; Zidovudine

1999
Reversible zidovudine-induced pure red cell aplasia.
    AIDS (London, England), 1999, Aug-20, Volume: 13, Issue:12

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Therapy, Combination; Hepatitis B, Chronic; Humans; Male; Middle Aged; Red-Cell Aplasia, Pure; Reverse Transcriptase Inhibitors; Zidovudine

1999
Reversible zidovudine-induced pure red-cell aplasia.
    AIDS (London, England), 1989, Volume: 3, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Humans; Red-Cell Aplasia, Pure; Zidovudine

1989